News
15h
MyNewsLA.com on MSNObese Woman Sues Anthem Over Zepbound Coverage Denial
An Anthem Blue Cross subscriber is suing the health insurer, alleging she was wrongfully denied coverage for Zepbound for weight management because she was no longer considered morbidly obese. Alicia ...
Superluminal will use its AI-driven platform to discover and optimize small-molecule treatments for G protein-coupled receptors, or GPCRs, which have emerged as a key to conditions such as diabetes ...
Amid pressure from the White House, U.S. drug companies are experimenting with direct-to-consumer sales models that cut out the middlemen.
4h
Zacks Investment Research on MSNWill New CEO's Leadership Propel Novo Nordisk's Next Growth Wave?
Novo Nordisk NVO recently underwent a major leadership transition, as Lars Fruergaard Jørgensen stepped down as CEO on Aug. 7 ...
The integration aims to simplify access to Zepbound for eligible members while providing comprehensive, whole-person care to ...
By Brooke Hudspeth, Pharm.D. University of Kentucky You’ve likely heard about glucagon-like peptide-1 agonists – usually ...
Texas Attorney General Ken Paxton has filed a lawsuit against pharmaceutical giant Eli Lilly for allegedly bribing and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results